Advamed Payment Alert: Breakthrough Pathway Payment for Medical Devices

August 9, 2019

level to 65 percent.

These changes represent significant wins for coverage and payment of innovative medical devices and are the latest in a series of payment policy victories that are the result of our multi-year advocacy efforts.

Key highlights of the final rule include the following:

• Alternative NTAP Pathway for Breakthrough Devices and QIDPs
• Change to the Calculation of the NTAP Payment Amount
• Clarifications to the Substantial Clinical Improvement Criterion
• New Technology Add-On Payments (NTAPs) Applications
• Antimicrobial Resistance Diagnoses as Complications and Comorbidities
• Payment Rate Update

Read the Press Release/Fact Sheet.